Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain

Abstract

Background Altered intestinal microbiota composition in later life is associated with inflammaging, declining tissue function, and increased susceptibility to age-associated chronic diseases, including neurodegenerative dementias. Here, we tested the hypothesis that manipulating the intestinal microbiota influences the development of major comorbidities associated with aging and, in particular, inflammation affecting the brain and retina. Methods Using fecal microbiota transplantation, we exchanged the intestinal microbiota of young (3 months), old (18 months), and aged (24 months) mice. Whole metagenomic shotgun sequencing and metabolomics were used to develop a custom analysis workflow, to analyze the changes in gut microbiota composition and metabolic potential. Effects of age and microbiota transfer on the gut barrier, retina, and brain were assessed using protein assays, immunohistology, and behavioral testing. Results We show that microbiota composition profiles and key species enriched in young or aged mice are successfully transferred by FMT between young and aged mice and that FMT modulates resulting metabolic pathway profiles. The transfer of aged donor microbiota into young mice accelerates age-associated central nervous system (CNS) inflammation, retinal inflammation, and cytokine signaling and promotes loss of key functional protein in the eye, effects which are coincident with increased intestinal barrier permeability. Conversely, these detrimental effects can be reversed by the transfer of young donor microbiota. Conclusions These findings demonstrate that the aging gut microbiota drives detrimental changes in the gut–brain and gut–retina axes suggesting that microbial modulation may be of therapeutic benefit in preventing inflammation-related tissue decline in later life. Graphical abstract

Absence of Bacteria Permits Fungal Gut-To-Brain Translocation and Invasion in Germfree Mice but Ageing Alone Does Not Drive Pathobiont Expansion in Conventionally Raised Mice

“…On the other hand, recent data show that long-term chronic administration of antibiotics can promote systemic dissemination of both fungi and bacteria ( Drummond et al, 2022 ). Advanced age is also associated with changing gut bacterial composition, as well as depleted barrier integrity promoting chronic systemic inflammageing ( Fransen et al, 2017 ; Thevaranjan et al, 2017 ; Parker et al, 2022 ). Therefore, we next investigated whether the composition of the enteric mycobiota is altered in aged animals, and whether any fungal species detected are potential pathobionts/opportunistic pathogens with the capacity to cause serious infection.…”

Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour

“…Inflammageing has been attributed increasing relevance in ageing studies. It is defined as a subclinical state characterised by chronic, sterile, and low-grade inflammation that plays a role in the development and progression of multiple ageing-related diseases, by contributing to the functional decline of tissues [ 51 , 52 , 53 ]. In the face of such ageing-related HP alterations and non-NE tumours throughout mice genotypes, we decided to explore collateral non-tumourigenic effects that could be assignable to Atrx loss in islet β cells, paying particular attention to the first year of the animals’ lives.…”

Effect of aging on acute pancreatitis through gut microbiota

“…However, the dramatic changes in the gut microbiota of aging patients have been ignored ( Lynch and Pedersen, 2016 ). Surprisingly, there has been a flurry of recent research on interventions by gut microbiota to ameliorate age-related diseases ( Bárcena et al, 2019 ; Parker et al, 2022 ). A study on the effect of gut microbiota from the elderly people and children on osteoporosis provided a research idea for our study ( Liu et al, 2021 ).…”